Captor Therapeutics ® Investor Relations
Menu Investor Relations Menu Investor Relations
Information on a transaction in shares of the Company obtained pursuant to Article 19 of MAR
Publication date: 2021-07-02
Number: RB ESPI 23/2021
Attachments:
Number: RB ESPI 23/2021
Current report no. 23/2021
Date of preparation: 2 July 2021
Subject: Information on a transaction in shares of the Company obtained pursuant to Article 19 of MAR
Legal basis: Article 19 sec. 3 of MAR – information on transactions executed by persons discharging managerial responsibilities
The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”) informs that it received from Paweł Holstinghausen Holsten, a member of the Supervisory Board of the Company, a notice of a transaction in shares of the Company referred to in Article 19 sec. 1 of MAR.
The text of the notice constitutes an appendix to this report.
Attachments: